In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
Sponsor: Emory University
Listed as NCT03932240, this PHASE3 trial focuses on Hemostasis and remains completed. Sponsored by Emory University, it has been updated 12 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Completed PHASE3
-
Apr 2023 — Mar 2024 [monthly]
Completed PHASE3
-
Apr 2022 — Apr 2023 [monthly]
Completed PHASE3
▶ Show 7 earlier versions
-
Sep 2021 — Apr 2022 [monthly]
Completed PHASE3
Status: Suspended → Completed
-
Jan 2021 — Sep 2021 [monthly]
Suspended PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Suspended PHASE3
Status: Recruiting → Suspended
-
Sep 2019 — Jun 2020 [monthly]
Recruiting PHASE3
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE3
-
Jun 2019 — Aug 2019 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
For direct contact, visit the study record on ClinicalTrials.gov .